HICKY Selected for the 2026 MedTech Innovator Accelerator Cohort

We are proud to share that HICKY, Inc. has been selected for the 2026 MedTech Innovator Accelerator Cohort. MedTech Innovator is the world’s largest accelerator for medical device, digital health, and diagnostic companies. The 2026 cohort represents the top 4% of 1,835 global applicants, with 65 companies selected from around the world. This selection is a meaningful external validation of HICKY’s technology, clinical need, and potential to address a significant unmet need in cardiovascular and sleep medicine. HICKY is developing a leadless implantable phrenic nerve stimulation platform designed to improve outcomes for patients with heart failure by treating central sleep apnea. For HICKY, this is an important milestone as we continue building our development strategy with the U.S. as our first priority, while keeping a broader global vision for patients who may benefit from this therapy. Over the coming months, we look forward to participating in MedTech Innovator’s mentorship, accelerator programming, industry events, and investor showcases as we continue advancing our clinical, regulatory, and market development strategy. Many thanks to our team, advisors, partners, mentors, investors, reviewers, and everyone who has believed in HICKY’s vision. We are excited for the journey ahead.